As of 2025-05-20, the Relative Valuation of BioPharma Credit PLC (BPCR.L) is 1.08 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of BioPharma Credit PLC based on Relative Valuation is 22.2%.
The range of the Relative Valuation is 0.84 - 1.40 USD.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 13.0x | 10.9x |
| Forward P/E multiples | 9.2x - 12.6x | 10.7x |
| Fair Price | 0.84 - 1.40 | 1.08 |
| Upside | -4.9% - 58.6% | 22.2% |
| Date | P/E |
| 2025-05-14 | 8.17 |
| 2025-05-13 | 8.21 |
| 2025-05-12 | 8.15 |
| 2025-05-09 | 8.21 |
| 2025-05-08 | 8.15 |
| 2025-05-07 | 8.08 |
| 2025-05-06 | 8.02 |
| 2025-05-02 | 7.95 |
| 2025-05-01 | 7.91 |
| 2025-04-30 | 7.89 |
| 2025-04-29 | 7.95 |
| 2025-04-28 | 7.91 |
| 2025-04-25 | 7.89 |
| 2025-04-24 | 7.93 |
| 2025-04-23 | 8.02 |
| 2025-04-22 | 7.95 |
| 2025-04-17 | 7.91 |
| 2025-04-16 | 7.80 |
| 2025-04-15 | 7.76 |
| 2025-04-14 | 7.67 |
| 2025-04-11 | 7.71 |
| 2025-04-10 | 7.67 |
| 2025-04-09 | 7.43 |
| 2025-04-08 | 7.76 |
| 2025-04-07 | 7.80 |
| 2025-04-04 | 7.97 |
| 2025-04-03 | 8.06 |
| 2025-04-02 | 8.19 |
| 2025-04-01 | 8.21 |
| 2025-03-31 | 8.19 |
| 2025-03-28 | 8.21 |
| 2025-03-27 | 8.12 |
| 2025-03-26 | 8.13 |
| 2025-03-25 | 8.12 |
| 2025-03-24 | 8.15 |
| 2025-03-21 | 8.21 |
| 2025-03-20 | 8.17 |
| 2025-03-19 | 8.17 |
| 2025-03-18 | 8.21 |
| 2025-03-17 | 8.23 |
| 2025-03-14 | 8.21 |
| 2025-03-13 | 8.17 |
| 2025-03-12 | 8.25 |
| 2025-03-11 | 8.19 |
| 2025-03-10 | 8.19 |
| 2025-03-07 | 8.12 |
| 2025-03-06 | 8.12 |
| 2025-03-05 | 8.02 |
| 2025-03-04 | 8.06 |
| 2025-03-03 | 8.08 |